Optimization of universal allogeneic CAR-T cells combining CRISPR and transposon-based technologies for treatment of acute myeloid leukemia
Palabras clave :
Allogeneic CAR-T; CRISPR; Transposon; AML; Transcriptomics (RNA sequencing),STEM-CELLS; RNA-SEQ; THERAPY; COSTIMULATION; INTEGRATION; SELECTION; INSERTION; DESIGN
AML
CRISPR
Allogeneic CAR-T
Transcriptomics (RNA sequencing)
Transposon.
Fecha de publicación :
2023
Nota:
This is an open-access article distributed
under the terms of the Creative Commons
Attribution License (CC BY)
Cita:
Calviño-Sampedro, C. (Cristina); Ceballos, C.; Alfonso-Piérola, A. (Ana); et al. "Optimization of universal allogeneic CAR-T cells combining CRISPR and transposon-based technologies for treatment of acute myeloid leukemia". Frontiers in Immunology. 14, 2023, 1270843
Aparece en las colecciones:
Estadísticas e impacto
0 citas en
Los ítems de Dadun están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.